1. Home
  2. PEN vs DSGX Comparison

PEN vs DSGX Comparison

Compare PEN & DSGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PEN
  • DSGX
  • Stock Information
  • Founded
  • PEN 2004
  • DSGX 1981
  • Country
  • PEN United States
  • DSGX Canada
  • Employees
  • PEN N/A
  • DSGX N/A
  • Industry
  • PEN Medical/Dental Instruments
  • DSGX Computer Software: Prepackaged Software
  • Sector
  • PEN Health Care
  • DSGX Technology
  • Exchange
  • PEN Nasdaq
  • DSGX Nasdaq
  • Market Cap
  • PEN 9.9B
  • DSGX 9.0B
  • IPO Year
  • PEN 2015
  • DSGX 1999
  • Fundamental
  • Price
  • PEN $256.09
  • DSGX $93.90
  • Analyst Decision
  • PEN Strong Buy
  • DSGX Buy
  • Analyst Count
  • PEN 16
  • DSGX 8
  • Target Price
  • PEN $302.93
  • DSGX $122.75
  • AVG Volume (30 Days)
  • PEN 432.3K
  • DSGX 474.8K
  • Earning Date
  • PEN 10-29-2025
  • DSGX 09-03-2025
  • Dividend Yield
  • PEN N/A
  • DSGX N/A
  • EPS Growth
  • PEN 916.05
  • DSGX 14.17
  • EPS
  • PEN 3.74
  • DSGX 1.69
  • Revenue
  • PEN $1,280,152,000.00
  • DSGX $684,781,000.00
  • Revenue This Year
  • PEN $15.52
  • DSGX $11.78
  • Revenue Next Year
  • PEN $14.20
  • DSGX $13.45
  • P/E Ratio
  • PEN $68.49
  • DSGX $54.45
  • Revenue Growth
  • PEN 12.92
  • DSGX 12.69
  • 52 Week Low
  • PEN $189.94
  • DSGX $91.00
  • 52 Week High
  • PEN $310.00
  • DSGX $124.31
  • Technical
  • Relative Strength Index (RSI)
  • PEN 47.86
  • DSGX 37.32
  • Support Level
  • PEN $242.41
  • DSGX $91.00
  • Resistance Level
  • PEN $257.56
  • DSGX $104.44
  • Average True Range (ATR)
  • PEN 7.03
  • DSGX 2.27
  • MACD
  • PEN -1.00
  • DSGX -0.93
  • Stochastic Oscillator
  • PEN 62.21
  • DSGX 21.58

About PEN Penumbra Inc.

Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.

About DSGX Descartes Systems Group Inc. (The)

Descartes Systems Group provides a software solution that allows users in the shipping industry to communicate with one another. Its core product is the Global Logistics Network, which is best understood as transaction-driven. Descartes charges clients to send/receive messages, data, and documents on the GLN. Customers typically contract for a monthly minimum over a multiyear period. The GLN platform allows Descartes to upsell additional software modules as well, typically provided via a software-as-a-service model.

Share on Social Networks: